Biomedical and toxico-chemical aspects of botulinum neurotoxins

Toxin Reviews

Volumn 18, Issue 1, 1999, Pages

  Singh, Bal Ram ^a  

^a UNIVERSITY OF MASSACHUSETTS DARTMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

CLOSTRIDIUM BOTULINUM; DRUG MECHANISM; EDITORIAL; HUMAN; NONHUMAN;

CLOSTRIDIUM BOTULINUM;

EID: 0032992257     PISSN: 15569543     EISSN: 15569551     Source Type: Journal    
DOI: 10.3109/15569549909036013     Document Type: Review

References (5)

1. Hatheway, C. L. (1989) Bacterial sources of clostridial neurotoxins. In Botulinum Neurotoxin and Tetanus Toxin (L. L. Simpson, ed.) pp. 3-24, Academic Press, San Diego.
2. Lamanna, C., MacElroy, O. E. and Eklund, H. W. (1946) The purification and crystallization of Clostridium botulinum type A toxin. Science 103, 613-614.
3. Zilinskas, R. A. (1997) Iraq's biological weapons. The past and future. J. Am. Med. Assoc. 278, 418-424. (Pubitemid 27327461)
4. Singh, B. R., Li, B. and Read, D. (1995) Botulinum versus tetanus neurotoxins: Why is botulinum neurotoxin a food poison but not tetanus? Toxicon 33, 1541-1547. (Pubitemid 26010040)
5. Maksymowych, A. B. and Simpson, L. L. (1998) Binding and transcytosis of botulinum neurotoxin by polarized human colon carcinoma cells. J. Biol. Chem. 273, 21950-21957. (Pubitemid 28405374)